{"relation": [["Valuation", "Price/Earnings", "Price/Sales", "Price/Book", "Price/Cash Flow", "TEV/Sales"], ["IMV", "NM", "--", "16.8x", "NM", "--"], ["Industry Range", "Not Meaningful", "Not Meaningful", "", "Not Meaningful", "Not Meaningful"]], "pageTitle": "IMMUNOVACCINE INC (IMV:Toronto): Stock Quote & Company Profile - Businessweek", "title": "", "url": "http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=IMV:CN", "hasHeader": true, "headerPosition": "FIRST_ROW", "tableType": "RELATION", "tableNum": 3, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988922.24/warc/CC-MAIN-20150728002308-00048-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 331488103, "recordOffset": 331464363, "tableOrientation": "HORIZONTAL", "TableContextTimeStampBeforeTable": "{37014=+1 212 318 2000, 36682=+65 6212 1000}", "TableContextTimeStampAfterTable": "{4808=Immunovaccine Inc., a clinical stage biopharmaceutical company, discovers and develops products that activate the immune system to treat cancer and prevent infectious diseases. The company develops its products based on the DepoVax vaccine-adjuvanting platform, which is a vaccine delivery formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. Its product pipeline includes DPX-Survivac, a therapeutic cancer vaccine, which has completed Phase I/Ib clinical trials for the treatment of ovarian cancer and is in Phase II clinical trials for the treatment of lymphoma cancer; DPX-0907, a therapeutic cancer vaccine that has completed Phase I/Ib clinical trials for the treatment of breast, ovarian, and prostate cancer; and DPX-RSV, which is in Phase I/Ib clinical trials for the treatment of respiratory diseases. The company also develops vaccines for infectious diseases, including bio-defense vaccines that would protect against anthrax and Ebola virus infection. In addition, it develops vaccine programs comprising addiction programs and animal health vaccine programs. Immunovaccine Inc. was founded in 2000 and is headquartered in Halifax, Canada.}", "textBeforeTable": "Industry Average IMV Industry Analysis \u00a0 // ]]> } document.write(BW_adsys('Right3')); if (window.BW_adsys) { // <script type=\"text/javascript\"> <div class=\"\" style=\"width:300px; margin: auto; \"> <div class=\"ad\"> </div> </table> </tbody> </tr> <td class=\"noDataRR\" style=\"border:none;\" colspan=\"3\"><a class=\"link_xs\" href=\"../../sectorandindustry/industries/industrydetail.asp?code=352010\">View Industry Companies</a></td> <tr> </tr> <td colspan=\"4\" align=\"center\">No competitor information is available for IMV.</td> <tr> <tbody> </thead> </tr> <td width=\"50\" align=\"right\">Change</td> <td width=\"75\" align=\"right\">Last</td> <td>Company</td> <tr> <thead> <table class=\"colRight\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\"> <div class=\"clear\"></div> </div> <p class=\"note fLeft\" style=\"width:64%; text-align: right; padding: 5px 0; border-top: 3px solid #6B7B84; margin-top: 20px;\">Market data is delayed at least 15 minutes.</p> <h2 class=\"sectionTitle fLeft\" style=\"width: 35%; border-bottom: 0;\">IMV Competitors</h2> <div style=\"border-bottom: 1px solid #ccc; overflow: hidden;\"> <div class=\"\"> </div> </table> </tbody> </tr> <td width=\"75\" align=\"right\" class=\"noBorder\"><img src=\"/cgi-bin/upload.dll/file.png?z05ae100az5b27f4dea2984a64be0bafe584f30ff0\" width=\"60\" height=\"15\" galleryimg=\"no\" symbol=\"CA;IMV\" /></td> <td align=\"right\" width=\"45\" class=\"noBorder\"><span class=\"posData\">+0.02</span></td> <td align=\"right\" class=\"noBorder\">C$1.19 <span class=\"xSmGreyTxt\">CAD</span></td> <td scope=\"row\"> <a class=\"link_xsb\" style=\"text-align:left\" target=\"_top\" href=\"../../stocks/snapshot/snapshot.asp?ticker=IMV:CN\"> IMV:CN </a> </td> <tr class=\"lastRow\"> <tbody> </thead> </tr> <td colspan=\"4\">Recently Viewed</td> <tr> <thead> <table class=\"miniTable\" summary=\"Recently viewed\"> </form> </fieldset> <a style=\"font-size:11px;\" target=\"_top\" href=\"../../common/symbollookup/symbollookup.asp\">Company Lookup</a> <input type=\"image\" name=\"submit\" src=\"http://images.businessweek.com/gen/buttons/stock_go_btn.gif\" align=\"absmiddle\" /> <input type=\"text\" id=\"lookupSymbol\" class=\"symbol\" autocomplete=\"off\" name=\"symbol\" value=\"Stock, Fund, or ETF\" onfocus=\"if(this.value == 'Stock, Fund, or ETF') this.value = '';\" onblur=\"if(this.value ==", "textAfterTable": "View Detailed IMV Financials \u00a0|\u00a0 View Sector Analysis Sponsored Financial Commentaries Sponsored Links Browse Companies A B C D E F G H I J K L M N O P Q R S T U V W X Y Z \u00a0|\u00a0 0 1 2 3 4 5 6 7 8 9 Report Data Issue To contact IMMUNOVACCINE INC, please visit www.imvaccine.com. Company data is provided by Capital IQ. Please use this form to report any data issues. Information Missing - Please enter your information in the following field(s): Company Name Your Name* Your E-Mail Address*", "hasKeyColumn": true, "keyColumnIndex": 0, "headerRowIndex": 0}